glp 1 and prostate cancer Glucagon-like peptide receptor agonists risk: advancing precision medicine through mechanistic understanding and clinical evidence | Biomarker Research Slimming down the tumor's 'fuel':

Much like in the brain, inflammation is a common feature in several ocular pathologies, particularly those relating to the retina

Very interesting paper on an important topic SGLT2is, GLP-1RAs and nsMRAs has significantly transformed clinical guidelines in recent decades shiowing numerous positive including CV and nephroprotection In type 2 diabetes, early evidence suggests that integrating these treatments may offer superior survival and cardiovascular outcomes compared to using single agents

For instance, in September 2025, the World Health Organization (WHO) updated its Model Lists of Essential Medicines (EML)

With its once-daily dosing and proven track record, Saxenda has been charming audiences and helping them reach their weight loss goals as well

Prasad, F